CERN - Cerner Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
74.48
-1.35 (-1.78%)
At close: 4:00PM EDT

74.48 0.00 (0.00%)
After hours: 4:28PM EDT

Stock chart is not supported by your current browser
Previous Close75.83
Open76.03
Bid74.46 x 1200
Ask74.47 x 800
Day's Range74.14 - 76.14
52 Week Range48.78 - 76.47
Volume2,523,013
Avg. Volume2,513,611
Market Cap24.236B
Beta (3Y Monthly)0.85
PE Ratio (TTM)38.81
EPS (TTM)1.92
Earnings DateJul 24, 2019
Forward Dividend & Yield0.72 (0.95%)
Ex-Dividend Date2019-06-17
1y Target Est71.39
Trade prices are not sourced from all markets
  • Omnicell (OMCL) Catches Eye: Stock Jumps 8.2%
    Zacks8 hours ago

    Omnicell (OMCL) Catches Eye: Stock Jumps 8.2%

    Omnicell (OMCL) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

  • Barrons.com3 days ago

    Why Nvidia Stock Will Rebound After a Brutal Stretch, According to a Fund Manager

    Todd Ahlsten, a Barron’s Roundtable panelist and lead portfolio manager of the Parnassus Core Equity fund at Parnassus Investments, sees a rally coming for beaten-up chip stock Nvidia

  • Tap AI-Powered Medical Device Stocks as FDA Bolsters SaMD
    Zacks4 days ago

    Tap AI-Powered Medical Device Stocks as FDA Bolsters SaMD

    The whole MedTech community finds a reason to cheer over with the FDA's recent proposal for Software as a Medical Device.

  • GlobeNewswire5 days ago

    Cerner to Release Second Quarter 2019 Earnings Results July 24

    Cerner Corporation (CERN) today announced it will release its second quarter 2019 earnings results after the market closes Wednesday, July 24. On the call, Cerner will discuss its results and outlook and answer questions from the investment community. An audio webcast will be available live and archived on Cerner’s website in the Investor Relations section.

  • MDRX vs. CERN: Which Stock Should Value Investors Buy Now?
    Zacks7 days ago

    MDRX vs. CERN: Which Stock Should Value Investors Buy Now?

    MDRX vs. CERN: Which Stock Is the Better Value Option?

  • Markit7 days ago

    See what the IHS Markit Score report has to say about Cerner Corp.

    Cerner Corp NASDAQ/NGS:CERNView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for CERN with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on June 19. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $3.66 billion over the last one-month into ETFs that hold CERN are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Cerner picks outsider to take over key C-level position
    American City Business Journals8 days ago

    Cerner picks outsider to take over key C-level position

    An executive with more than 20 years of experience in health care, including nearly 10 years in executive HR roles at Medtronic, will join Cerner as its new chief human resources officer. She succeeds Julie Wilson, who spent 16 of her 24 years with Cerner in the role of chief people officer, leading the company's dramatic hiring efforts.

  • GlobeNewswire8 days ago

    Cerner Announces New Chief Human Resources Officer

    Cerner (CERN), a global health platform and innovation company, announced today that Tracy Platt will join the company as its new Executive Vice President and Chief Human Resources Officer. Platt has more than 20 years of experience and joins Cerner after spending nearly 10 years in executive HR roles at Medtronic, a global health care giant that develops and distributes medical devices.

  • Who Has Been Selling Cerner Corporation (NASDAQ:CERN) Shares?
    Simply Wall St.11 days ago

    Who Has Been Selling Cerner Corporation (NASDAQ:CERN) Shares?

    It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...

  • Walgreens Boots (WBA) Q3 Earnings Top Estimates, Margins Dip
    Zacks19 days ago

    Walgreens Boots (WBA) Q3 Earnings Top Estimates, Margins Dip

    Walgreens Boots' (WBA) Retail Pharmacy USA division gains traction from comparable prescription volume growth and a sturdy retail prescription market.

  • Boston Scientific Strong on Growth Goals and Future Launches
    Zacks19 days ago

    Boston Scientific Strong on Growth Goals and Future Launches

    This long-range strategy will aid Boston Scientific (BSX) to deliver a solid financial footing across its MedSurg, Rhythm and Neuro plus Cardiovascular segments.

  • Teleflex (TFX) Shares Down on Respiratory Care Product Recall
    Zacks21 days ago

    Teleflex (TFX) Shares Down on Respiratory Care Product Recall

    Teleflex (TFX) issued a statement saying consumers who own the tampered product should immediately discontinue use and return all affected products.

  • Bruker (BRKR) Hits a 52-Week High on Solid Growth Drivers
    Zacks21 days ago

    Bruker (BRKR) Hits a 52-Week High on Solid Growth Drivers

    Bruker (BRKR) gains from several crucial product launches and acquisitions.

  • Hill-Rom (HRC) Gains on Product Launch, Prudent Buyouts
    Zacks22 days ago

    Hill-Rom (HRC) Gains on Product Launch, Prudent Buyouts

    The contribution from new products is substantial to bolster top-line growth during the first half of fiscal 2019 at Hill-Rom (HRC).

  • Here's Why You Should Hold GNC Holdings (GNC) Stock for Now
    Zacks22 days ago

    Here's Why You Should Hold GNC Holdings (GNC) Stock for Now

    GNC Holdings (GNC) continues to witness investors' confidence, courtesy of a few positive factors like strategic new partnerships.

  • Bruker (BRKR) Launches the MALDI Biotyper Sirius System
    Zacks22 days ago

    Bruker (BRKR) Launches the MALDI Biotyper Sirius System

    The launch is a milestone for Bruker (BRKR) in assay research and clinical studies for fast antibiotic-resistance testing.

  • IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength
    Zacks25 days ago

    IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength

    IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.

  • Here's Why You Should Add Hologic (HOLX) to Your Portfolio
    Zacks25 days ago

    Here's Why You Should Add Hologic (HOLX) to Your Portfolio

    Hologic (HOLX) is generating consistent positive results, courtesy of growth initiatives.

  • Hologic (HOLX) Inks Deal to Acquire SuperSonic Imagine
    Zacks25 days ago

    Hologic (HOLX) Inks Deal to Acquire SuperSonic Imagine

    The acquisition of SuperSonic Imagine is in sync with Hologic's (HOLX) strategy to provide wide-ranging screening, interventional and surgical solutions.

  • QIAGEN Inks Distribution Deal With Mckesson Medical-Surgical
    Zacks26 days ago

    QIAGEN Inks Distribution Deal With Mckesson Medical-Surgical

    The distribution agreement will enable QIAGEN (QGEN) to expand reach in the healthcare market.

  • Haemonetics on a High Owing to Firm Plasma Arm, Global Growth
    Zacks27 days ago

    Haemonetics on a High Owing to Firm Plasma Arm, Global Growth

    Continued traction in new business wins and expansion of geographies are lifting Haemonetics' (HAE) performance of late.

  • Here's Why You Should Invest in Haemonetics (HAE) Stock Now
    Zacks27 days ago

    Here's Why You Should Invest in Haemonetics (HAE) Stock Now

    Haemonetics (HAE) benefits from impressive uptick of Hemostasis Management revenues.

  • NuVasive Grows on Strong Product Adoption Amid Pricing Woe
    Zacks28 days ago

    NuVasive Grows on Strong Product Adoption Amid Pricing Woe

    Introduction of multiple products within the Spinal Hardware, balanced revenue growth across key operating segments and robust international sales perk up NuVasive's (NUVA) share price.

  • Haemonetics' Plant Sell-Off to CLS Plasma to be Strategic Fit
    Zacks28 days ago

    Haemonetics' Plant Sell-Off to CLS Plasma to be Strategic Fit

    This impending divestment remains integral to Haemonetics' (HAE) asset optimization strategy that aims at improving its operational performance and focusing on core competencies.